263 related articles for article (PubMed ID: 462161)
21. Ascites in cirrhosis: a review of management and complications.
Kuiper JJ; van Buuren HR; de Man RA
Neth J Med; 2007 Sep; 65(8):283-8. PubMed ID: 17890787
[TBL] [Abstract][Full Text] [Related]
22. [Management of life threatening diuretic-resistant ascites by ultrafiltration and reinfusion of the ascitic fluid after dialysis].
Kara J; Wórum I; Csornal A; Középesy L
Orv Hetil; 1989 Jul; 130(28):1497-9. PubMed ID: 2748167
[TBL] [Abstract][Full Text] [Related]
23. Treatment of cirrhotic ascites.
Schouten J; Michielsen PP
Acta Gastroenterol Belg; 2007; 70(2):217-22. PubMed ID: 17715638
[TBL] [Abstract][Full Text] [Related]
24. The rational management of ascites.
Conn HO
Prog Liver Dis; 1972; 4():269-88. PubMed ID: 4581860
[No Abstract] [Full Text] [Related]
25. [The use of peritoneal port-systems in the treatment of diuretic-resistant cirrhotic ascites].
Abdurakhmanov BA; Gantsev ShKh; Kulakeev OK
Khirurgiia (Mosk); 2010; (4):30-3. PubMed ID: 20517235
[TBL] [Abstract][Full Text] [Related]
26. Physiologic considerations in the medical management of ascites.
Frakes JT
Arch Intern Med; 1980 May; 140(5):620-3. PubMed ID: 7396587
[TBL] [Abstract][Full Text] [Related]
27. [Experience in the treatment of diuretic-resistant ascites in liver cirrhosis by intravenous infusion of autogenous ascitic fluid].
Matsuoka K; Ueda Y; Kimura M; Mashiba Y; Kitsuki K
Naika; 1971; 28(1):163-7. PubMed ID: 5565686
[No Abstract] [Full Text] [Related]
28. Furosemide-induced natriuresis as a test to identify cirrhotic patients with refractory ascites.
Spahr L; Villeneuve JP; Tran HK; Pomier-Layrargues G
Hepatology; 2001 Jan; 33(1):28-31. PubMed ID: 11124817
[TBL] [Abstract][Full Text] [Related]
29. [Intravenous re-infusion of ascitic fluid in patients with treatment-resistant cirrhotic ascites (author's transl)].
Gerke G
Dtsch Med Wochenschr; 1979 Jan; 104(3):95-8. PubMed ID: 759157
[TBL] [Abstract][Full Text] [Related]
30. Management of ascites in cirrhosis.
Sandhu BS; Sanyal AJ
Clin Liver Dis; 2005 Nov; 9(4):715-32, viii. PubMed ID: 16207572
[TBL] [Abstract][Full Text] [Related]
31. [Concentration and reinfusion of ascitic fluid in liver cirrhosis].
Mian G; Triolo L; Magris D; de Savorgnani MN; G'Agnolo B
Minerva Med; 1979 Sep; 70(42):2869-72. PubMed ID: 492554
[TBL] [Abstract][Full Text] [Related]
32. Pathogenesis of ascites and renal salt retention in cirrhosis.
Palmer BF
J Investig Med; 1999 May; 47(5):183-202. PubMed ID: 10361377
[TBL] [Abstract][Full Text] [Related]
33. Long-term renal sodium handling in patients with cirrhosis treated with transjugular intrahepatic portosystemic shunts for refractory ascites.
Wong W; Liu P; Blendis L; Wong F
Am J Med; 1999 Mar; 106(3):315-22. PubMed ID: 10190381
[TBL] [Abstract][Full Text] [Related]
34. Guidelines on the management of ascites in cirrhosis.
Moore KP; Aithal GP
Gut; 2006 Oct; 55 Suppl 6(Suppl 6):vi1-12. PubMed ID: 16966752
[No Abstract] [Full Text] [Related]
35. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club.
Moore KP; Wong F; Gines P; Bernardi M; Ochs A; Salerno F; Angeli P; Porayko M; Moreau R; Garcia-Tsao G; Jimenez W; Planas R; Arroyo V
Hepatology; 2003 Jul; 38(1):258-66. PubMed ID: 12830009
[TBL] [Abstract][Full Text] [Related]
36. [Modern therapy of ascites in liver cirrhosis].
Brodanová M
Vnitr Lek; 1995 Mar; 41(3):189-92. PubMed ID: 7762178
[TBL] [Abstract][Full Text] [Related]
37. Clinical experience with autogenous ascitic fluid infusion for cirrhotic ascites.
Graziano JL; Reinhardt GF; Howell HS; Hacker LC; Stanley MM
Am Surg; 1977 Aug; 43(8):520-3. PubMed ID: 889189
[TBL] [Abstract][Full Text] [Related]
38. Are ascitic electrolytes usable in cirrhotic patients? Correlation of sodium, potassium, chloride, urea, and creatinine concentrations in ascitic fluid and blood.
Nguyen-Khac E; Thevenot T; Capron D; Dharancy S; Paupart T; Thabut D; Tiry C
Eur J Intern Med; 2008 Dec; 19(8):613-8. PubMed ID: 19046728
[TBL] [Abstract][Full Text] [Related]
39. Experimental, clinical, and metabolic results of side-to-side portacaval shunt for intractable cirrhotic ascites.
Orloff MJ; Orloff MS; Orloff SL; Girard B
J Am Coll Surg; 1997 Jun; 184(6):557-70. PubMed ID: 9179111
[TBL] [Abstract][Full Text] [Related]
40. [Role of surgery in the treatment of refractory ascites in cirrhotic patients].
Borie DC; Vaillant JC; Breton S; Hannoun L
Ann Chir; 1999; 53(10):966-72. PubMed ID: 10670142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
